home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/cac77f04-4821-4774-a4b0-5dfb573a2853_challenge.pdf
whitepaper
SHARESHARESHARE
PHARMA 2020: CHALLENGING BUSINESS MODELS WHICH PATH WILL YOU TAKE?
The pharmaceutical marketplace is undergoing huge changes, as we indicated in “Pharma 2020: The vision”, the White Paper PricewaterhouseCoopers* published in June 2007.1 These changes will have a major bearing on the kind of business models pharmaceutical companies need to employ. Most Big Pharma companies have traditionally done everything from research and development (R&D) through to commercialization themselves. But we predict that, by 2020, this model will no longer work for many organizations. If they are to prosper, they will need to improve their R&D productivity, reduce their costs, tap the potential of the emerging economies and switch from selling medicines to managing outcomes – activities few, if any, companies can accomplish on their own. DOWNLOAD